在CFTR相关疾病中发现新的CFTR单元型E583G/F508del
Elisa De Paolis1,2, Bruno Tilocca3, Riccardo Inchingolo4
1Departmental Unit of Molecular and Genomic Diagnostics, Genomics Core Facility, Gemelli Science and Technology Park (G-STeP), Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, 00168, Italy.
Molecular biology reports
|July 25, 2024
概括
研究人员在患有CFTR相关疾病 (CFTR-RD) 的患者身上研究了一种罕见的CFTR变异E583G. 该研究确定了一种新的CFTR原型 (F508del/E583G),并提供了E583G变体的证据.
科学领域:
- 遗传学和分子生物学
- 肺部病理学 肺部病理学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 与CFTR相关的疾病 (CFTR-RD) 提出了复杂的诊断挑战.
- CFTR基因型定型是CFTR-RD的关键诊断标记物.
- 新的CFTR单元类型需要彻底的分子评估.
研究的目的:
- 描述罕见的CFTR变异E583G的分子评估.
- 在患有CFTR-RD.的患者中分析一种新的CFTR单元型 (F508del/E583G).
- 使用生物信息学评估E583G变种的致病性.
主要方法:
- 利用下一代测序用于CFTR基因分析.
- 综合临床证据与生物信息学分析的变异性致病性.
- 评估了一名患有持续呼吸道症状和单器官CFTR-RD诊断的患者.
主要成果:
- 确定了一种新的CFTR单元型:F508del/E583G.
- 生物信息学分析表明,E583G变种具有有害影响.
- 患者提出了一个单器官CFTR-RD诊断.
结论:
- 新的CFTR单元类型需要综合评估,结合临床和分子数据.
- 该E583G变种对CFTR-RD具有潜在的临床兴趣.
- 这一发现有助于理解CFTR-RD变异的不同临床后果 (VVC).
更多相关视频
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
19.2K
15:12Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
Published on: May 10, 2014
14.5K
相关概念视频
Cystic Fibrosis: Pathogenesis
202
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
202
Cystic Fibrosis: Management
154
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
154
